Skip to Content
You are currently on the new version of our website. Access the old version .

248 Results Found

  • Article
  • Open Access
8 Citations
4,061 Views
10 Pages

Antithrombin Activity and Association with Risk of Thrombosis and Mortality in Patients with Cancer

  • Cornelia Englisch,
  • Oliver Königsbrügge,
  • Stephan Nopp,
  • Florian Moik and ,
  • Peter Quehenberger,
  • Matthias Preusser,
  • Ingrid Pabinger and
  • Cihan Ay
  • + 3 authors+ 0 author

12 December 2022

Venous and arterial thromboembolism (VTE/ATE) are common complications in cancer patients. Antithrombin deficiency is a risk factor for thrombosis in the general population, but its connection to risk of cancer-associated thrombosis is unclear. We in...

(This article belongs to the Special Issue Frontiers in Thrombosis)
  • Article
  • Open Access
1,210 Views
13 Pages

β-Antithrombin Levels in Patients with Venous Thromboembolism

  • Edith Alexandra Uj,
  • Éva Molnár,
  • Tünde Miklós,
  • Réka Gindele and ,
  • Amir Houshang Shemirani,
  • Zsuzsanna Bereczky and
  • Éva Katona
  • + 2 authors+ 0 author

18 November 2025

Beta-antithrombin (β-AT), the isoform of antithrombin (AT) with a higher affinity for heparin, constitutes 5–10% of total AT in plasma. There are limited data regarding β-AT activity levels in thrombotic disorders. In our study, we an...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Article
  • Open Access
6 Citations
3,665 Views
16 Pages

Anti-Tumor Functions of Prelatent Antithrombin on Glioblastoma Multiforme Cells

  • Julia Peñas-Martínez,
  • Ginés Luengo-Gil,
  • Salvador Espín,
  • Nataliya Bohdan and ,
  • Carmen Ortega-Sabater,
  • Maria Carmen Ródenas,
  • David Zaragoza-Huesca,
  • María José López-Andreo,
  • Carme Plasencia and
  • Irene Martínez-Martínez
  • + 7 authors+ 2 authors

Antithrombin, the main physiological inhibitor of the coagulation cascade, exerts anti-tumor effects on glioblastoma multiforme cells. Antithrombin has different conformations: native, heparin-activated, prelatent, latent, and cleaved. The prelatent...

(This article belongs to the Special Issue Cancer Metastasis and Therapeutic Resistance)
  • Article
  • Open Access
18 Citations
4,884 Views
18 Pages

Investigation of the Differences in Antithrombin to Heparin Binding among Antithrombin Budapest 3, Basel, and Padua Mutations by Biochemical and In Silico Methods

  • Réka Gindele,
  • Krisztina Pénzes-Daku,
  • Gábor Balogh,
  • Judit Kállai and ,
  • Réka Bogáti,
  • Bálint Bécsi,
  • Ferenc Erdődi,
  • Éva Katona and
  • Zsuzsanna Bereczky
  • + 4 authors+ 0 author

8 April 2021

Antithrombin (AT) is a serine protease inhibitor, its activity is highly accelerated by heparin. Mutations at the heparin-binding region lead to functional defect, type II heparin-binding site (IIHBS) AT deficiency. The aim of this study was to inves...

  • Article
  • Open Access
3 Citations
3,120 Views
19 Pages

Clinical and Molecular Characterization of Nine Novel Antithrombin Mutations

  • Judit Kállai,
  • Réka Gindele,
  • Krisztina Pénzes-Daku,
  • Gábor Balogh and ,
  • Réka Bogáti,
  • Bálint Bécsi,
  • Éva Katona,
  • Zsolt Oláh,
  • Péter Ilonczai and
  • Zsuzsanna Bereczky
  • + 9 authors+ 4 authors

Antithrombin (AT) is the major plasma inhibitor of thrombin (FIIa) and activated factor X (FXa), and antithrombin deficiency (ATD) is one of the most severe thrombophilic disorders. In this study, we identified nine novel AT mutations and investigate...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Article
  • Open Access
4 Citations
2,513 Views
11 Pages

Background: We aimed to investigate the effects of antithrombin III administration on the prognosis of severe trauma patients with disseminated intravascular coagulation (DIC). Methods: Medical records of a total of 4023 patients who were admitted to...

(This article belongs to the Section Critical Care)
  • Article
  • Open Access
1 Citations
3,245 Views
9 Pages

Plasma Antithrombin Activity during Long-Term Magnesium Sulfate Administration for Preeclampsia without Severe Hypertension

  • Kaori Moriuchi,
  • Kaoru Kawasaki,
  • Maako Hayashi,
  • Akihiko Ueda and ,
  • Yukio Yamanishi,
  • Haruta Mogami,
  • Kohei Fujita,
  • Reona Shiro,
  • Yoshie Yo and
  • Noriomi Matsumura
  • + 6 authors+ 1 author

19 August 2022

In preeclampsia, plasma antithrombin activity is decreased, which leads to exacerbation of the disorder. We previously showed that long-term magnesium sulfate (MgSO4) administration prolonged the pregnancy period and may be able to improve pregnancy...

(This article belongs to the Special Issue Diagnosis, Prevention, Treatment and Medical Care for Gynecologic and Perinatal Diseases)
  • Article
  • Open Access
26 Citations
4,084 Views
9 Pages

Newly Developed Recombinant Antithrombin Protects the Endothelial Glycocalyx in an Endotoxin-Induced Rat Model of Sepsis

  • Toshiaki Iba,
  • Jerrold H. Levy,
  • Koichiro Aihara,
  • Katsuhiko Kadota and ,
  • Hiroshi Tanaka,
  • Koichi Sato and
  • Isao Nagaoka
  • + 2 authors+ 0 author

26 December 2020

(1) Background: The endothelial glycocalyx is a primary target during the early phase of sepsis. We previously reported a newly developed recombinant non-fucosylated antithrombin has protective effects in vitro. We further evaluated the effects of th...

(This article belongs to the Section Biochemistry)
  • Review
  • Open Access
62 Citations
8,876 Views
13 Pages

Antithrombin and Its Role in Host Defense and Inflammation

  • Christine Schlömmer,
  • Anna Brandtner and
  • Mirjam Bachler

Antithrombin (AT) is a natural anticoagulant that interacts with activated proteases of the coagulation system and with heparan sulfate proteoglycans (HSPG) on the surface of cells. The protein, which is synthesized in the liver, is also essential to...

(This article belongs to the Section Biochemistry)
  • Article
  • Open Access
14 Citations
5,246 Views
12 Pages

N-Glycosylation as a Tool to Study Antithrombin Secretion, Conformation, and Function

  • Sonia Águila,
  • Rosina Noto,
  • Ginés Luengo-Gil,
  • Salvador Espín and ,
  • Nataliya Bohdan,
  • María Eugenia de la Morena-Barrio,
  • Julia Peñas,
  • Maria Carmen Rodenas,
  • Vicente Vicente and
  • Irene Martínez-Martínez
  • + 7 authors+ 2 authors

N-linked glycosylation is a crucial post-translational modification involved in protein folding, function, and clearance. N-linked glycosylation is also used therapeutically to enhance the half-lives of many proteins. Antithrombin, a serpin with four...

(This article belongs to the Special Issue Protein Folding)
  • Communication
  • Open Access
2 Citations
3,163 Views
8 Pages

Association of COVID-19 Vaccines ChAdOx1-S and BNT162b2 with Circulating Levels of Coagulation Factors and Antithrombin

  • Amal Hasan,
  • Hossein Arefanian,
  • Arshad Mohamed Channanath,
  • Irina AlKhairi and ,
  • Preethi Cherian,
  • Sriraman Devarajan,
  • Thangavel Alphonse Thanaraj,
  • Mohamed Abu-Farha,
  • Jehad Abubaker and
  • Fahd Al-Mulla
  • + 5 authors+ 0 author

31 July 2022

Background: Severe coronavirus disease 2019 (COVID-19) is associated with increased risk of thrombosis and thromboembolism. Exposure to COVID-19 vaccines is also associated with immune thrombotic thrombocytopenia, ischemic stroke, intracerebral haemo...

(This article belongs to the Section COVID-19 Vaccines and Vaccination)
  • Article
  • Open Access
1 Citations
5,222 Views
12 Pages

Effect of Immobilized Antithrombin III on the Thromboresistance of Polycarbonate Urethane

  • Karin Lukas,
  • Karin Stadtherr,
  • Andre Gessner,
  • Daniel Wehner and ,
  • Thomas Schmid,
  • Hans Peter Wendel,
  • Christof Schmid and
  • Karla Lehle
  • + 3 authors+ 0 author

24 March 2017

The surface of foils and vascular grafts made from a thermoplastic polycarbonate urethanes (PCU) (Chronoflex AR) were chemically modified using gas plasma treatment, binding of hydrogels—(1) polyethylene glycol bisdiamine and carboxymethyl dextran (P...

(This article belongs to the Section Biomaterials)
  • Article
  • Open Access
9 Citations
2,539 Views
9 Pages

2 June 2023

Persistent inflammation, immunosuppression, and catabolism syndrome (PICS) is a serious condition after critical care. We examined the efficacy of antithrombin, which may attenuate coagulopathy with the control of inflammation, for PICS among patient...

(This article belongs to the Section Intensive Care)
  • Article
  • Open Access
9 Citations
3,476 Views
13 Pages

Functional Characterization of Antithrombin Mutations by Monitoring of Thrombin Inhibition Kinetics

  • Sara Reda,
  • Jens Müller,
  • Anna Pavlova,
  • Behnaz Pezeshkpoor and ,
  • Johannes Oldenburg,
  • Bernd Pötzsch and
  • Heiko Rühl
  • + 2 authors+ 0 author

20 February 2021

Inactivation of thrombin by the endogenous inhibitor antithrombin (AT) is a central mechanism in the regulation of hemostasis. This makes hereditary AT deficiency, which is caused by SERPINC1 gene mutations, a major thrombophilic risk factor. Aim of...

(This article belongs to the Section Biochemistry)
  • Article
  • Open Access
2 Citations
1,034 Views
24 Pages

11 October 2025

The inactivation of thrombin by antithrombin is highly enhanced by the presence of heparin chains forming “bridges” between the two proteins. X-ray structures for such ternary complexes have been published, but the molecular background of...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Article
  • Open Access
10 Citations
4,034 Views
10 Pages

Usefulness and Limitations of Multiple Ligation-Dependent Probe Amplification in Antithrombin Deficiency

  • Rosa Cifuentes,
  • José Padilla,
  • María Eugenia de la Morena-Barrio,
  • Belén de la Morena-Barrio and ,
  • Carlos Bravo-Pérez,
  • Pedro Garrido-Rodríguez,
  • María Llamas,
  • Antonia Miñano,
  • Vicente Vicente and
  • Javier Corral
  • + 6 authors+ 1 author

Multiplex ligation-dependent probe amplification (MLPA) identifies genetic structural variants in SERPINC1 in 5% of cases with antithrombin deficiency (ATD), the most severe congenital thrombophilia. Our aim was to unravel the utility and limitations...

(This article belongs to the Special Issue Genetic, Functional and Therapeutic Aspects of Procoagulant and Anticoagulant Factors)
  • Review
  • Open Access
14 Citations
5,010 Views
15 Pages

18 October 2022

Recent research has contributed significantly to our understanding of the pathogenesis of acute disseminated intravascular coagulation. COVID-19 can be considered as a new underlying condition of disseminated intravascular coagulation. In this narrat...

(This article belongs to the Special Issue Sepsis: From Molecular Mechanisms, Pathophysiology to Novel Therapeutic Approaches 2.0)
  • Article
  • Open Access
5 Citations
2,352 Views
22 Pages

Antithrombin (AT) is a critical regulator of the coagulation cascade by inhibiting multiple coagulation factors including thrombin and FXa. Binding of heparinoids to this serpin enhances the inhibition considerably. Mutations located in the heparin b...

(This article belongs to the Section Molecular Structure and Dynamics)
  • Article
  • Open Access
2 Citations
3,009 Views
10 Pages

Low Preoperative Antithrombin III Level Is Associated with Postoperative Acute Kidney Injury after Liver Transplantation

  • Kyoung-Sun Kim,
  • Young-Jin Moon,
  • Sung-Hoon Kim,
  • Bomi Kim and ,
  • In-Gu Jun,
  • Hye-Mee Kwon,
  • Jun-Gol Song and
  • Gyu-Sam Hwang
  • + 3 authors+ 0 author

26 July 2021

We aimed to determine the association between the preoperative antithrombin III (ATIII) level and postoperative acute kidney injury (AKI) after LT (post-LT AKI). We retrospectively evaluated 2395 LT recipients between 2010 and 2018 whose data of peri...

(This article belongs to the Special Issue Personalized Medicine for Liver Disease: From Molecular Mechanisms to Potential Targeted Therapies)
  • Article
  • Open Access
17 Citations
3,391 Views
11 Pages

Plasma Antithrombin III Levels Can Be a Prognostic Factor in Liver Cirrhosis Patients with Portal Vein Thrombosis

  • Tsuyoshi Suda,
  • Hajime Takatori,
  • Takehiro Hayashi,
  • Kiichiro Kaji and ,
  • Kouki Nio,
  • Takeshi Terashima,
  • Tetsuro Shimakami,
  • Kuniaki Arai,
  • Tatsuya Yamashita and
  • Taro Yamashita
  • + 9 authors+ 4 authors

Liver function influences the plasma antithrombin (AT)-III levels. AT-III is beneficial for patients with portal vein thrombosis (PVT) and low plasma AT-III levels. However, whether these levels affect prognosis in patients with cirrhosis-associated...

(This article belongs to the Special Issue New Advances in Thrombosis)
  • Article
  • Open Access
2 Citations
4,204 Views
13 Pages

Antithrombin III (ATIII) is a potent endogenous anticoagulant that binds to heparan sulfate proteoglycans (HSPGs) on endothelial cells’ surfaces. Among these HSPGs, syndecans (SDCs) are crucial as transmembrane receptors bridging extracellular...

(This article belongs to the Special Issue Coronavirus Disease (COVID-19): Pathophysiology 5.0)
  • Article
  • Open Access
20 Citations
6,758 Views
15 Pages

9 November 2022

Ischemic strokes are one of the leading causes of death worldwide. The aim of this meta-analysis is to elaborate on the role of inherited predisposition to thrombophilia in the etiology of ischemic strokes in young adults. The keywords factor V Leide...

(This article belongs to the Section Molecular Genetics and Genomics)
  • Article
  • Open Access
3 Citations
2,542 Views
21 Pages

The interaction between coagulation factors Xa and IXa and the activated state of their inhibitor, antithrombin (AT),have been investigated using X-ray diffraction studies. However, only mutagenesis data are available for non-activated AT. Our aim wa...

(This article belongs to the Section Molecular Structure and Dynamics)
  • Article
  • Open Access
9 Citations
4,085 Views
14 Pages

Detection of Unknown and Rare Pathogenic Variants in Antithrombin, Protein C and Protein S Deficiency Using High-Throughput Targeted Sequencing

  • Petr Vrtel,
  • Ludek Slavik,
  • Radek Vodicka,
  • Julia Stellmachova and ,
  • Martin Prochazka,
  • Jana Prochazkova,
  • Jana Ulehlova,
  • Peter Rohon,
  • Tomas Simurda and
  • Radek Vrtel
  • + 7 authors+ 2 authors

The deficiency of natural anticoagulants—antithrombin (AT), protein C (PC), and protein S (PS)—is a highly predisposing factor for thrombosis, which is still underdiagnosed at the genetic level. We aimed to establish and evaluate an optim...

(This article belongs to the Special Issue Diagnosis for Hematologic Disorders)
  • Review
  • Open Access
7 Citations
3,278 Views
20 Pages

Activated Factor VII–Antithrombin Complex, a Biomarker of Tissue Factor-Related Pathways in Different Clinical Settings: A Narrative Review from Cardiovascular Diseases to Cancer

  • Sara Moruzzi,
  • Annalisa Castagna,
  • Marianna Spizzo,
  • Silvia Udali and ,
  • Patrizia Pattini,
  • Francesca Pizzolo,
  • Simonetta Friso and
  • Nicola Martinelli
  • + 3 authors+ 0 author

Tissue factor (TF) is a transmembrane glycoprotein that represents the fundamental physiological initiator of the coagulation cascade through its interaction with factor VII. TF belongs to the cytokine receptor protein superfamily and contributes to...

(This article belongs to the Collection Biomarkers in Medicine)
  • Article
  • Open Access
448 Views
18 Pages

9 September 2026

Background: Hyperuricemic nephropathy (UAN) involves a systemic thromboinflammatory axis, yet the role of antithrombin (AT, SERPINC1) remains incompletely defined. While AT has anticoagulant and anti-inflammatory properties, whether it contributes to...

(This article belongs to the Special Issue Genetic and Genomic Insights into the Pathogenesis of Kidney Disease)
  • Article
  • Open Access
6 Citations
3,456 Views
12 Pages

High Plasma Levels of Activated Factor VII-Antithrombin Complex Point to Increased Tissue Factor Expression in Patients with SARS-CoV-2 Pneumonia: A Potential Link with COVID-19 Prothrombotic Diathesis

  • Nicola Martinelli,
  • Anna Maria Rigoni,
  • Sergio De Marchi,
  • Nicola Osti and ,
  • Martino Donini,
  • Martina Montagnana,
  • Annalisa Castagna,
  • Patrizia Pattini,
  • Silvia Udali and
  • Francesca Pizzolo
  • + 19 authors+ 14 authors

14 November 2022

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causal agent of coronavirus disease 2019 (COVID-19), in which coagulation abnormalities and endothelial dysfunction play a key pathogenic role. Tissue factor (TF) expression is trigg...

(This article belongs to the Section Diagnostic Microbiology and Infectious Disease)
  • Feature Paper
  • Article
  • Open Access
5 Citations
2,315 Views
12 Pages

Usefulness of Combined Measurement of Surfactant Protein D, Thrombin–Antithrombin III Complex, D-Dimer, and Plasmin–α2 Plasmin Inhibitor Complex in Acute Exacerbation of Interstitial Lung Disease: A Retrospective Cohort Study

  • Yuichiro Takeshita,
  • Masako To,
  • Yusuke Kurosawa,
  • Naho Furusho and ,
  • Toru Kinouchi,
  • Kenji Tsushima,
  • Yuji Tada,
  • Yasuo To and
  • Seiichiro Sakao
  • + 4 authors+ 0 author

21 April 2024

Background/Objectives: The coagulation cascade due to tissue damage is considered to be one of the causes of poor prognostic outcomes in patients with acute exacerbations of interstitial lung disease (AE-ILD). This study aimed to confirm coagulopathy...

(This article belongs to the Special Issue Clinical Advances in Interstitial Lung Diseases)
  • Article
  • Open Access
18 Citations
2 Views
6 Pages

Thrombin Antithrombin Complex and IL-18 Serum Levels in Stroke Patients

  • Ornella Piazza,
  • Giuliana Scarpati,
  • Simona Cotena,
  • Maria Lonardo and
  • Rosalba Tufano

10 February 2010

The complex picture of inflammation and coagulation alterations comes to life in acute stroke phases. Increasing evidence points to a strong interaction and extensive crosstalk between the inflammation and coagulation systems: the interest towards th...

  • Article
  • Open Access
2 Citations
1,453 Views
20 Pages

15 September 2025

The allosteric activation of antithrombin (AT) involves a conformational shift from a native, repressed (R) to a heparin-bound, activated (AH) state. Using computational structural analysis, we identified an evolutionarily conserved allosteric commun...

(This article belongs to the Section Molecular Biology)
  • Article
  • Open Access
13 Citations
4,586 Views
16 Pages

Role of Autophagy in Von Willebrand Factor Secretion by Endothelial Cells and in the In Vivo Thrombin-Antithrombin Complex Formation Promoted by the HIV-1 Matrix Protein p17

  • Antonella Bugatti,
  • Stefania Marsico,
  • Pietro Mazzuca,
  • Kai Schulze and ,
  • Thomas Ebensen,
  • Cinzia Giagulli,
  • Esther Peña,
  • Lina Badimón,
  • Mark Slevin and
  • Francesca Caccuri
  • + 7 authors+ 2 authors

Although the advent of combined antiretroviral therapy has substantially improved the survival of HIV-1-infected individuals, non-AIDS-related diseases are becoming increasingly prevalent in HIV-1-infected patients. Persistent abnormalities in coagul...

(This article belongs to the Special Issue Autophagy in Health, Ageing and Disease)
  • Article
  • Open Access
23 Citations
5,357 Views
19 Pages

Anti-Thrombin, Anti-Adhesive, Anti-Migratory, and Anti-Proliferative Activities of Sulfated Galactans from the Tropical Green Seaweed, Udotea flabellum

  • Maxsuell Lucas Mendes Marques,
  • Fernando Bastos Presa,
  • Rony Lucas Silva Viana,
  • Mariana Santana Santos Pereira Costa and ,
  • Monica Oliveira Rocha Amorim,
  • Daniel Lima Bellan,
  • Monique Gabriela Chagas Faustino Alves,
  • Leandro Silva Costa,
  • Edvaldo Silva Trindade and
  • Hugo Alexandre Oliveira Rocha
  • + 5 authors+ 0 author

21 December 2018

In this study, sulfated polysaccharide-rich extracts were isolated from 22 tropical seaweeds (4 red, 11 brown, and 7 green) found in northeastern Brazil, and evaluated for the role of anticoagulant agents. Fifteen of the extracts showed anticoagulant...

(This article belongs to the Special Issue Screening for Marine Natural Products with Potential as Chemotherapeutics)
  • Editorial
  • Open Access
546 Views
4 Pages

Antithrombin Treatment Strategies for Patients with ST-Elevation Myocardial Infarction

  • Nils Kucher,
  • Otto Martin Hess,
  • Christoph Kaiser,
  • Pierre-Frederic Keller and ,
  • Michael Pieper and
  • Bernhard Meier
  • + 1 author+ 0 author

26 September 2008

Appropriate antithrombotic therapy in patients with ST-elevation myocardial infarction (STEMI) helps reducing major cardiovascular events and bleeding complications. The majority of patients presenting with STEMI in Switzerland are referred for early...

  • Article
  • Open Access
1 Citations
1,818 Views
14 Pages

Automated Antithrombin Activity Detection with Whole Capillary Blood Based on Digital Microfluidic Platform

  • Dongshuo Li,
  • Hanqi Hu,
  • Hanzhi Zhang,
  • Lei Shang and ,
  • Tao Zhao,
  • Qingchen Zhao,
  • Shuhao Zhang,
  • Fucun Ma,
  • Guowei Liang and
  • Xuekai Liu
  • + 6 authors+ 1 author

30 June 2025

Antithrombin (AT) plays a crucial role in the human anticoagulant system and has extensive clinical applications. However, traditional detection methods often require large sample volumes, complex procedures, and lengthy processing times. Methods: We...

(This article belongs to the Special Issue Advances in Microfluidic Chips for Chemical and Biomedical Applications)
  • Article
  • Open Access
1 Citations
683 Views
13 Pages

An Exploratory Pilot Study of Coagulation- and Fibrinolysis-Related Proteins in Unexplained Infertility

  • Manjula Nandakumar,
  • Abu Saleh Md Moin,
  • Thozhukat Sathyapalan,
  • Alexandra E. Butler and
  • Stephen L. Atkin

Unexplained infertility (UI) accounts for an estimated 15–30% of infertility but its biological basis remains poorly defined. Plasma haemostatic abnormalities have been implicated in recurrent pregnancy loss; however, whether the circulating co...

(This article belongs to the Special Issue Molecular Targets in Reproductive Diseases)
  • Review
  • Open Access
453 Views
5 Pages

Antithrombin Treatment of Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

  • Nils Kucher,
  • Stephan Windecker,
  • Francois Mach,
  • Pierre-Frederic Keller and ,
  • Christan Roguelov and
  • Bernhard Meier
  • + 1 author+ 0 author

Antithrombotic therapy in patients with acute coronary syndromes (ACS) targets activated platelets, thrombin, and certain clotting factors, and has been shown to improve clinical outcomes, including recurrent myocardial infarction and cardiovascular...

  • Review
  • Open Access
49 Citations
12,810 Views
19 Pages

Inherited Thrombophilia in the Era of Direct Oral Anticoagulants

  • Lina Khider,
  • Nicolas Gendron and
  • Laetitia Mauge

5 February 2022

Severe inherited thrombophilia includes rare deficiencies of natural anticoagulants (antithrombin and proteins C and S) and homozygous or combined factor V Leiden and FII G20210A variants. They are associated with a high thrombosis risk and can impac...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Article
  • Open Access
5 Citations
4,343 Views
19 Pages

Short Term Treatment Monitoring of Renal and Inflammatory Biomarkers with Naturally Occurring Leishmaniosis: A Cohort Study of 30 Dogs

  • Valeria Pantaleo,
  • Tommaso Furlanello,
  • Michela Campigli,
  • Laura Ventura and
  • Laia Solano-Gallego

22 October 2024

Various inflammatory and renal biomarkers have already been assessed for monitoring the response to anti-leishmanial therapy in canine leishmaniosis. This study assessed the parasite load, various inflammatory and renal biomarkers pre- and post-treat...

(This article belongs to the Section Veterinary Internal Medicine)
  • Article
  • Open Access
2 Citations
2,563 Views
19 Pages

Differential Solvent DEEP-STD NMR and MD Simulations Enable the Determinants of the Molecular Recognition of Heparin Oligosaccharides by Antithrombin to Be Disentangled

  • Michela Parafioriti,
  • Stefano Elli,
  • Juan C. Muñoz-García,
  • Jonathan Ramírez-Cárdenas and ,
  • Edwin A. Yates,
  • Jesús Angulo and
  • Marco Guerrini
  • + 2 authors+ 0 author

The interaction of heparin with antithrombin (AT) involves a specific sequence corresponding to the pentasaccharide GlcNAc/NS6S-GlcA-GlcNS3S6S-IdoA2S-GlcNS6S (AGA*IA). Recent studies have revealed that two AGA*IA-containing hexasaccharides, which dif...

(This article belongs to the Section Biochemistry)
  • Article
  • Open Access
2,106 Views
13 Pages

23 March 2026

Yamakagashi (Rhabdophis tigrinus) is a widely distributed snake species in Japan. Yamakagashi causes venom-induced consumption coagulopathy (VICC) when the amount of infused venom is high, and bites can be fatal if antivenom treatment is delayed. How...

(This article belongs to the Section Animal Venoms)
  • Article
  • Open Access
8 Citations
6,860 Views
16 Pages

Low Molecular Weight Heparins (LMWH) are complex anticoagulant drugs that mainly inhibit the blood coagulation cascade through indirect interaction with antithrombin. While inhibition of the factor Xa is well described, little is known about the poly...

(This article belongs to the Special Issue Looking Forward to the Future of Heparin: New Sources, Developments and Applications)
  • Article
  • Open Access
4 Citations
1,563 Views
17 Pages

Comparative Study of Hirudins and Encoding Genes in Hirudo nipponia and Hirudo tianjinensis

  • Jingjing Yin,
  • Zichao Liu,
  • Yunfei Yu,
  • Anping Wang and ,
  • Zuhao Huang,
  • Lizhou Tang,
  • Fang Zhao and
  • Gonghua Lin
  • + 3 authors+ 0 author

11 September 2025

This study systematically compared the genetic characteristics and functional activities of hirudins and their encoding genes between Hirudo nipponia (Hnip1–3) and Hirudo tianjinensis (Htia1–3) through bioinformatics analysis, recombinant...

(This article belongs to the Section Biochemistry and Molecular Biology)
  • Review
  • Open Access
30 Citations
4,700 Views
9 Pages

4 November 2019

Many systematic reviews have been published regarding anticoagulant therapy in sepsis, among which there is substantial heterogeneity. This study aimed to provide an overview of existing systematic reviews of randomized controlled trials by using a c...

(This article belongs to the Special Issue Sepsis: Immunopathology, Patient Classification and Clinical Management)
  • Case Report
  • Open Access
1 Citations
4,302 Views
9 Pages

Acute Eosinophilic Pneumonia Complicated with Venous Thromboembolic Disease—Diagnostic and Therapeutic Considerations

  • Ewa Jankowska,
  • Iwona Bartoszuk,
  • Katarzyna Lewandowska,
  • Małgorzata Dybowska and ,
  • Lucyna Opoka,
  • Witold Tomkowski and
  • Monika Szturmowicz
  • + 2 authors+ 0 author

Acute Eosinophilic Pneumonia (AEP) is a rare idiopathic disease caused by an accumulation of eosinophils in the pulmonary alveoli and interstitial tissue of the lungs. The onset of symptoms is acute; some patients develop respiratory failure. The dia...

(This article belongs to the Special Issue Advances in the Diagnosis of Interstitial Lung Diseases)
  • Article
  • Open Access
78 Citations
8,997 Views
14 Pages

Biological Effects of Chitosan-Based Dressing on Hemostasis Mechanism

  • Yi-Wen Wang,
  • Chuan-Chieh Liu,
  • Juin-Hong Cherng,
  • Chien-Seng Lin and ,
  • Shu-Jen Chang,
  • Zhi-Jie Hong,
  • Cheng-Che Liu,
  • Yaw-Kwan Chiu,
  • Sheng-Der Hsu and
  • Hung Chang
  • + 5 authors+ 0 author

19 November 2019

There have been numerous recent advances in wound care management. Nevertheless, the assessment of hemostatic dressing is essential to enable surgeons and other physicians and healthcare professionals to make the correct decisions regarding the dispo...

(This article belongs to the Special Issue Chitin and Chitosan: Properties and Applications)
  • Case Report
  • Open Access
2,045 Views
8 Pages

Massive Central Pulmonary Embolism with Riding Embolus and Concomitant Aortic Arch Embolism—Should We Diagnose Patients Earlier for Blood Clotting Disorders? Case Report

  • Anna Lis,
  • Paweł Kowalski,
  • Marcin Wita,
  • Tomasz Zawadzki and ,
  • Tomasz Ilczak,
  • Wojciech Żurawiński and
  • Mateusz Majewski
  • + 2 authors+ 0 author

Paradoxical embolism occurs when a clot originates in the venous system and traverses through a pulmonary or intracardiac shunt into the systemic circulation, with a mortality rate of around 18%. The risk factors for arterial embolism and venous thro...

  • Article
  • Open Access
3 Citations
1,667 Views
16 Pages

Procoagulant Effects of Bothrops diporus Venom: Kinetic Modeling and Role of Serine Protease Activity

  • Gisela L. Lopez,
  • Sarah A. Nielsen,
  • Vance G. Nielsen and
  • Luciano S. Fusco

28 September 2025

Bothrops species are responsible for the majority of envenomations in Argentina. In particular, Bothrops diporus is among the main species responsible for the majority of envenomations in Argentina and causes significant injury and coagulopathy. Give...

(This article belongs to the Special Issue Molecular Mechanisms of Venom and Antivenom)
  • Feature Paper
  • Article
  • Open Access
11 Citations
4,143 Views
15 Pages

2 December 2019

Due to the biological properties of heparin and low-molecular-weight heparin (LMWH), continuous advances in elucidation of their microheterogeneous structure and discovery of novel structural peculiarities are crucial. Effective strategies for monito...

(This article belongs to the Special Issue Emerging Frontiers in Glycosaminoglycans and Mimetics)
  • Article
  • Open Access
8 Citations
3,395 Views
11 Pages

Biocompatibility Parameters with Standard and Increased Dose of Citrate in Hemodialysis—A Randomized Trial

  • Alesa Orsag,
  • Mojca Bozic-Mijovski,
  • Samo Hudoklin,
  • Sasa Simcic and
  • Jakob Gubensek

4 July 2021

Background: The dose of citrate needed in regional citrate anticoagulation (RCA) to achieve optimal biocompatibility is unknown. We performed a randomized trial comparing two doses (ACTRN12613001340729). Methods: In 30 patients a single hemodialysis...

(This article belongs to the Collection Clinical Research and Advances in Hemodialysis)
  • Article
  • Open Access
5 Citations
2,822 Views
27 Pages

Can Coagulation System Disorders and Cytokine and Inflammatory Marker Levels Predict the Temporary Clinical Deterioration or Improvement of Septic Patients on ICU Admission?

  • Georgia-Athanasia Lavranou,
  • Spyros Mentzelopoulos,
  • Paraskevi Katsaounou,
  • Ilias Siempos and ,
  • Ioannis Kalomenidis,
  • Aikaterini Geranaki,
  • Christina Routsi and
  • Spyros Zakynthinos
  • + 3 authors+ 0 author

7 April 2021

Although coagulation disorders and immune/inflammatory response have been associated with the final outcome of patients with sepsis, their link with thetemporaryclinical deterioration or improvement of patients is unknown. We aimed to investigate thi...

(This article belongs to the Section Emergency Medicine)

of 5